Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients.
Jang JY, Lee SH, Kim BS, Seo HS, Kim WS, Ahn Y, Lee NH, Koh KK, Kang TS, Jo SH, Hong BK, Bae JH, Yang HM, Cha KS, Kim BS, Kwak CH, Cho DK, Kim U, Zo JH, Kang DH, Pyun WB, Chun KJ, Namgung J, Cha TJ, Juhn JH, Jung Y, Jang Y. Jang JY, et al. Among authors: lee sh, lee nh. Korean Circ J. 2015 Jul;45(4):349. doi: 10.4070/kcj.2015.45.4.349. Korean Circ J. 2015. PMID: 26240593 Free PMC article.
An unusual type of hypertrophic cardiomyopathy.
Seo HS, Kim DH, Kim EJ, Yoo HY, Kim C, Lee CH, Kim BY, Chung CH, Suh J, Cho YH, Lee NH. Seo HS, et al. Among authors: lee ch, lee nh. Korean Circ J. 2009 May;39(5):213-6. doi: 10.4070/kcj.2009.39.5.213. Epub 2009 May 28. Korean Circ J. 2009. PMID: 19949582 Free PMC article.
Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical study.
Youn JC, Ihm SH, Bae JH, Park SM, Jeon DW, Jung BC, Park TH, Lee NH, Song JM, Yoon YW, Shin ES, Sung KC, Jung IH, Pyun WB, Joo SJ, Park WJ, Shin JH, Kang SM. Youn JC, et al. Among authors: lee nh. Clin Ther. 2014 Oct 1;36(10):1412-21. doi: 10.1016/j.clinthera.2014.07.004. Epub 2014 Aug 3. Clin Ther. 2014. PMID: 25092393 Clinical Trial.
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients.
Jang JY, Lee SH, Kim BS, Seo HS, Kim WS, Ahn Y, Lee NH, Koh KK, Kang TS, Jo SH, Hong BK, Bae JH, Yang HM, Cha KS, Kim BS, Kwak CH, Cho DK, Kim U, Zo JH, Kang DH, Pyun WB, Chun KJ, Namgung J, Cha TJ, Juhn JH, Jung Y, Jang Y. Jang JY, et al. Among authors: lee sh, lee nh. Korean Circ J. 2015 May;45(3):225-33. doi: 10.4070/kcj.2015.45.3.225. Epub 2015 May 27. Korean Circ J. 2015. PMID: 26023311 Free PMC article.
Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study.
Kim SH, Jo SH, Lee SC, Lee SY, Yoon MH, Lee HL, Lee NH, Ha JW, Lee NH, Kim DW, Han GR, Hyon MS, Cho DG, Park CG, Kim YD, Ryu GH, Kim CH, Kim KS, Chung MH, Chae SC, Seung KB, Oh BH. Kim SH, et al. Among authors: lee hl, lee sy, lee nh, lee sc. Clin Ther. 2016 Oct;38(10):2171-2184. doi: 10.1016/j.clinthera.2016.09.005. Epub 2016 Oct 12. Clin Ther. 2016. PMID: 27742464 Free article. Clinical Trial.
Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
Ihm SH, Jeon HK, Cha TJ, Hong TJ, Kim SH, Lee NH, Yoon JH, Yoon N, Hwang KK, Jo SH, Youn HJ. Ihm SH, et al. Among authors: lee nh. Drug Des Devel Ther. 2016 Nov 23;10:3817-3826. doi: 10.2147/DDDT.S116847. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27920497 Free PMC article. Clinical Trial.
A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.
Ahn Y, Kim Y, Chang K, Kim W, Rhee MY, Cha KS, Hyon MS, Shim CY, Lee SY, Kim DI, Kim SW, Lim SW, Han KR, Jo SH, Lee NH, Kwan J, Ahn T. Ahn Y, et al. Among authors: lee sy, lee nh. Medicine (Baltimore). 2018 Sep;97(37):e12329. doi: 10.1097/MD.0000000000012329. Medicine (Baltimore). 2018. PMID: 30212981 Free PMC article. Clinical Trial.
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion.
Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, Kang H, Kang SJ, Kim YH, Lee CW, Park SW, Hur SH, Rha SW, Her SH, Choi SW, Lee BK, Lee NH, Lee JY, Cheong SS, Kim MH, Ahn YK, Lim SW, Lee SG, Hiremath S, Santoso T, Udayachalerm W, Cheng JJ, Cohen DJ, Muramatsu T, Tsuchikane E, Asakura Y, Park SJ. Lee SW, et al. Among authors: lee cw, lee sg, lee bk, lee ph, lee nh, lee jy. Circulation. 2019 Apr 2;139(14):1674-1683. doi: 10.1161/CIRCULATIONAHA.118.031313. Circulation. 2019. PMID: 30813758 Clinical Trial.
807 results